Lars Ekman - 19 May 2021 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role
Director, Chairman of the Board
Signature
/s/ Michael J. Malecek, as attorney-in-fact for Lars G. Ekman
Issuer symbol
PRTA
Transactions as of
19 May 2021
Net transactions value
$0
Form type
4
Filing time
21 May 2021, 17:03:52 UTC
Next filing
16 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRTA Stock Option (Right to Buy) Award $0 +15,000 $0.000000 15,000 19 May 2021 Ordinary Shares 15,000 $23.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.